Research

Today, the focus of MDA-supported research in Lambert-Eaton myasthenic syndrome, as it is for other autoimmune (self-immune) diseases, is largely on regulating the immune response.

Several research groups are working on rebalancing the errant immune system, so that it returns to a state where it is able to attack invading microbes but not the body's own tissues. One especially promising avenue in this regard is increasing the activity or numbers of so-called regulatory T cells, which can dampen an overactive, or misdirected, immune response.

For more details on the above, see New Directions: Can an immune response be rerouted to treat disease?

Disease: